FEMY

Femasys Inc

FEMY, USA

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

https://www.femasys.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
FEMY
stock
FEMY

Femasys Secures Major Order for FemBloc Launch MSN

Read more →
FEMY
stock
FEMY

Price Action: Can FEMY stock attract ESG capital inflows - GDP Growth & AI Powered Trade Plan Recommendations moha.gov.vn

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$5.1667

Analyst Picks

Strong Buy

2

Buy

2

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

5.43

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-92.07 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-25.75 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-765.25 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

2.58

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 19.32% of the total shares of Femasys Inc

1.

Dauntless Investment Group, LLC

(7.1243%)

since

2025/06/30

2.

Vanguard Group Inc

(2.922%)

since

2025/06/30

3.

Vanguard Total Stock Mkt Idx Inv

(1.9016%)

since

2025/07/31

4.

Clear Creek Investment Mgmt LLC

(0.8651%)

since

2025/06/30

5.

Geode Capital Management, LLC

(0.7717%)

since

2025/06/30

6.

CM Management, LLC

(0.6907%)

since

2025/06/30

7.

Vanguard Institutional Extnd Mkt Idx Tr

(0.6724%)

since

2025/07/31

8.

Royal Bank of Canada

(0.5005%)

since

2025/06/30

9.

UBS Group AG

(0.3755%)

since

2025/06/30

10.

Fidelity Extended Market Index

(0.3538%)

since

2025/07/31

11.

Citadel Advisors Llc

(0.3263%)

since

2025/06/30

12.

BlackRock Inc

(0.2981%)

since

2025/06/30

13.

Jane Street Group LLC

(0.2593%)

since

2025/06/30

14.

State Street Corp

(0.173%)

since

2025/06/30

15.

Northern Trust Corp

(0.1643%)

since

2025/06/30

16.

iShares Micro-Cap ETF

(0.1614%)

since

2025/08/31

17.

Fidelity Total Market Index

(0.1561%)

since

2025/07/31

18.

HRT FINANCIAL LLC

(0.1491%)

since

2025/06/30

19.

Advisor Group Holdings, Inc.

(0.1444%)

since

2025/06/30

20.

Nwf Advisory Services Inc

(0.1444%)

since

2025/03/31

21.

Fidelity Series Total Market Index

(0.1026%)

since

2025/07/31

22.

Global Retirement Partners, LLC.

(0.1012%)

since

2025/06/30

23.

Tri Locum Partners LP

(0.094%)

since

2025/06/30

24.

Extended Equity Market Fund K

(0.0926%)

since

2025/06/30

25.

NT Ext Equity Mkt Idx Fd - NL

(0.0871%)

since

2025/06/30

26.

Sontag Advisory LLC

(0.0864%)

since

2025/06/30

27.

Spartan Extended Market Index Pool F

(0.083%)

since

2025/07/31

28.

Ocean Capital Management, LLC

(0.0745%)

since

2025/06/30

29.

Northern Trust Extended Eq Market Idx

(0.0736%)

since

2025/06/30

30.

NT Ext Equity Mkt Idx Fd - L

(0.0736%)

since

2025/06/30

31.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0676%)

since

2025/06/30

32.

Northwestern Mutual Wealth Management Co

(0.0614%)

since

2025/06/30

33.

Fidelity Nasdaq Composite Index

(0.0558%)

since

2025/07/31

34.

Spartan Total Market Index Pool G

(0.0366%)

since

2025/07/31

35.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0208%)

since

2025/06/30

36.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0175%)

since

2024/12/31

37.

1290 VT Micro Cap K

(0.0144%)

since

2025/06/30

38.

Extended Equity Market Fund M

(0.0117%)

since

2025/06/30

39.

State St US Extended Mkt Indx NL Cl C

(0.0037%)

since

2025/08/31

40.

Northern Trust Wilshire 5000

(0.0036%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.1

EPS Estimate

-0.1267

EPS Difference

0.0267

Surprise Percent

21.0734%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(3)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(1.5)
Value
Overpriced(2)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.